Lupin buys 3 anti-diabetes trademarks from Boehringer Ingelheim Ruchika Sharma14 Dec 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET and AJADUO from...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Lupin RnD facility in Pune bags LEED Platinum Certification Ruchika Sharma5 Dec 2024 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that its R&D facility at Lupin Research Park, Pune has been awarded the LEED Platinum...
Lupin gets tentative USFDA nod for Sitagliptin, Metformin Hydrochloride Tablets to treat type 2 diabetes Ruchika Sharma29 Nov 2024 3:32 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
Dr Reddy's Labs unit, Lupin arm recall products in US Ruchika Sharma26 Nov 2024 11:30 AM ISTDr Reddy's Labs, Lupin are recalling products in the US, according to the US Food and Drug Administration (USFDA).A US-based unit of Dr Reddy's...
Lupin's generic drug to treat ADHD symptoms gets USFDA approval Farhat Nasim20 Nov 2024 2:57 PM ISTMumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its...
Lupin launches generic equivalent of Bumex Injection in US Farhat Nasim20 Nov 2024 12:43 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) announced on Tuesday the launch of Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose...
Lupin to focus on development of inhalers with near-zero global warming potential propellants Ruchika Sharma3 Nov 2024 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a propellant with...
Lupin launches first generic of Pred Forte in US with 180-day exclusivity MD Bureau16 Oct 2024 1:39 PM ISTPred Forte had estimated annual sales of USD 198 million in the U.S. (IQVIA MAT August 2024)
Lupin gets 5 USFDA observations for Pune biotech facility Ruchika Sharma7 Oct 2024 11:30 AM ISTMumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...
Lupin arm buys nine brands of Medical Nutritional Institute in South Africa Ruchika Sharma5 Oct 2024 12:30 PM ISTThe acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance.
Lupin, Scope Ophthalmics Ireland ink pact to market Optase range of products in Mexico Ruchika Sharma2 Oct 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics Ireland (SCOPE) for the...
